Close the sale of the Group Disability and Life business
Not delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 6 Feb 2020
- Due
- 30 Sep 2020
- Checked
- 8 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“We expect the transaction to close in the third quarter of 2020, subject to applicable regulatory approvals and other customary closing conditions.”
What we found
Evidence strength A What the grades mean
Cigna failed to close the sale of its Group Disability and Life business by the original third-quarter 2020 deadline, subsequently revising its expectation to the fourth quarter of 2020.
-
A Cigna 10-Q filed 2020-11-05
“The sale is expected to close in the fourth quarter of 2020 subject to applicable regulatory approvals and other customary closing conditions.” ✓ confirmed on the page
Market reaction: the shares moved -2.9% against the S&P 500 over the three sessions around the disclosure (4 Nov 2020 to 9 Nov 2020). What this measures
Checked 8 Oct 2026.
Commitment lineage
Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.
- Deadline drift +92 days
- 2 versions
-
Version 1 · original · stated 6 Feb 2020
Deadline 30 Sep 2020 (“in the third quarter of 2020”) · wording expected
-
Version 2 · stated 5 Nov 2020
Deadline 31 Dec 2020 (“in the fourth quarter of 2020”) · wording expected
“Cigna continues to expect the transaction to close in the fourth quarter of 2020, subject to applicable regulatory approvals and other customary closing conditions.”
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Sale of Group Disability and Life business
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: applicable regulatory approvals; customary closing conditions
- Depends on
- Regulatory, Counterparty
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Cigna? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-CI-005400 · Corrections policy